A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE

被引：6
|
作者：
Descamps, Olivier S. [1 ,2 ]
Cooney, Marie Therese [3 ]
De Backer, Guy [4 ]
Graham, Ian [3 ]
机构：
[1] Hop Jolimont, Ctr Rech Med Jolimont, B-7100 Haine St Paul, Belgium
[2] Hop Jolimont, Dept Med Interne, B-7100 Haine St Paul, Belgium
[3] Adelaide & Meath Hosp, Dept Cardiol, Dublin 24, Ireland
[4] Ghent Univ Hosp, Dept Cardiol, Ghent, Belgium
来源：
ATHEROSCLEROSIS | 2012年 / 222卷 / 02期
关键词：
SCORE; Cardiovascular risk; Risk assessment; Prevention; HDL cholesterol; Guidelines; GUIDELINES; DISEASE;
D O I：
10.1016/j.atherosclerosis.2012.03.035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The 2011 ESC-EAS guidelines on the management of dyslipidaemias use four separate charts to illustrate the impact of differing HDL cholesterol levels on risk of cardiovascular disease. We developed an easy way to calculate the effects of differing HDL-C levels on risk by deriving HDL and sex specific multipliers and applying these to various reference charts. Of three strategies explored, one based on a low HDL (0.8 mmol/l) reference chart was the simplest and was acceptably accurate. Such an approach simplifies risk estimation by avoiding the need for multiple charts. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：564 / 566
页数：3
相关论文
共 50 条
  • [1] HDL cholesterol and cardiovascular risk
    Ghali, William A.
    Rodondi, Nicolas
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 338
  • [2] Ten years cardiovascular risk estimation according to Framingham score and non HDL-cholesterol in blood donors
    Mabel Nora, Graffigna
    Gabriela, Berg
    Marta, Migliano
    Pablo, Salgado
    Jimena, Soutelo
    Carla, Musso
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2015, 9 (01) : 24 - 27
  • [3] HDL-cholesterol modulation and its impact on the management of cardiovascular risk
    Ferns, Gordon
    Keti, Vuyolethu
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 122 - 128
  • [4] HDL: Fact, fiction, or function? HDL cholesterol and cardiovascular risk
    Allard-Ratick, Marc P.
    Kindya, Bryan R.
    Khambhati, Jay
    Engels, Marc C.
    Sandesara, Pratik B.
    Rosenson, Robert S.
    Sperling, Laurence S.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (02) : 166 - 173
  • [5] HDL CHOLESTEROL AS CARDIOVASCULAR RISK FACTOR IN UREMIA
    DELAVELLE, F
    TROMBERT, JC
    CANARELLI, G
    KIDNEY INTERNATIONAL, 1979, 16 (01) : 94 - 94
  • [6] Dissociating HDL cholesterol from cardiovascular risk
    Hausenloy, Derek J.
    Opie, Lionel
    Yellon, Derek M.
    LANCET, 2010, 376 (9738): : 305 - 306
  • [7] Variation in HDL cholesterol methodology and calibration may lead to erroneous cardiovascular risk estimation
    Delanghe, J. R.
    De Buyzere, M. L.
    Rietzschel, E.
    De Backer, G.
    De Bacquer, D.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A146 - A146
  • [8] How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators
    Cooney, Marie Therese
    Dudina, Alexandra
    De Bacquer, Dirk
    Fitzgerald, Anthony
    Conroy, Ronan
    Sans, Susana
    Menotti, Alessandro
    De Backer, Guy
    Jousilahti, Pekka
    Keil, Ulrich
    Thomsen, Troels
    Whincup, Peter
    Graham, Ian
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (03): : 304 - 314
  • [9] Impact Of Pemafibrate On Triglyceride To Hdl-cholesterol Ratio And Risk Of Adverse Cardiovascular Events
    Imamura, Teruhiko
    Kinugawa, Koichiro
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 590 - 590
  • [10] HDL Cholesterol, Apolipoproteins, and Cardiovascular Risk in Hemodialysis Patients
    Silbernagel, Guenther
    Genser, Bernd
    Drechsler, Christiane
    Scharnagl, Hubert
    Grammer, Tanja B.
    Stojakovic, Tatjana
    Krane, Vera
    Ritz, Eberhard
    Wanner, Christoph
    Maerz, Winfried
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (02): : 484 - 492
12345